Advisor Shares Investments LLC Fsd Pharma Inc. Transaction History

Advisor Shares Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$1.07 - $1.6 $14,624 - $21,868	-13,668 Reduced 5.48%	235,637 $285,000
Q2 2023 Aug 09, 2023	SELL	$0.99 - $2.04 $32,743 - $67,470	-33,074 Reduced 11.71%	249,305 $286,000
Q1 2023 May 09, 2023	SELL	$0.77 - $1.81 $66,605 - $156,565	-86,500 Reduced 23.45%	282,379 $437,000
Q4 2022 Feb 14, 2023	SELL	$0.73 - $1.07 $61,064 - $89,505	-83,650 Reduced 18.49%	368,879 $291,000
Q3 2022 Nov 14, 2022	BUY	$0.78 - $1.02 $113,663 - $148,636	145,722 Added 47.5%	452,529 $380,000

Q2 2022 Aug 08, 2022	BUY	$0.78 - $1.1 $106,373 - $150,013	136,376 Added 80.02%	306,807 $242,000
Q1 2022 May 09, 2022	BUY	$0.82 - $1.1 $139,753 - $187,474	170,431 New	170,431 $148,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Advisor Shares Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Advisor Shares Investments LLC with notifications on news.